Advances in the prevention and treatment of breast cancer-related lymphedema
Top Cited Papers
Open Access
- 27 April 2023
- journal article
- review article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 200 (1) , 1-14
Abstract
Purpose: Breast cancer-related lymphedema (BCRL) represents a lifelong risk for breast cancer survivors and once acquired becomes a lifelong burden. This review summarizes current BCRL prevention and treatment strategies. Findings: Risk factors for BCRL have been extensively studied and their identification has affected breast cancer treatment practice, with sentinel lymph node removal now standard of care for patients with early stage breast cancer without sentinel lymph node metastases. Early surveillance and timely management aim to reduce BCRL incidence and progression, and are further facilitated by patient education, which many breast cancer survivors report not having adequately received. Surgical approaches to BCRL prevention include axillary reverse mapping, lymphatic microsurgical preventative healing (LYMPHA) and Simplified LYMPHA (SLYMPHA). Complete decongestive therapy (CDT) remains the standard of care for patients with BCRL. Among CDT components, facilitating manual lymphatic drainage (MLD) using indocyanine green fluorescence lymphography has been proposed. Intermittent pneumatic compression, nonpneumatic active compression devices, and low-level laser therapy appear promising in lymphedema management. Reconstructive microsurgical techniques such as lymphovenous anastomosis and vascular lymph node transfer are growing surgical considerations for patients as well as liposuction-based procedures for addressing fatty fibrosis formation from chronic lymphedema. Long-term self-management adherence remains problematic, and lack of diagnosis and measurement consensus precludes a comparison of outcomes. Currently, no pharmacological approaches have proven successful. Conclusion: Progress in prevention and treatment of BCRL continues, requiring advances in early diagnosis, patient education, expert consensus and novel treatments designed for lymphatic rehabilitation following insults.Keywords
Funding Information
- PureTech Health plc
This publication has 136 references indexed in Scilit:
- Lymphatic and Angiogenic Candidate Genes Predict the Development of Secondary Lymphedema following Breast Cancer SurgeryPLOS ONE, 2013
- Effects of manual lymphatic drainage on breast cancer-related lymphedema: a systematic review and meta-analysis of randomized controlled trialsWorld Journal of Surgical Oncology, 2013
- Reduced Incidence of Breast Cancer–Related Lymphedema following Mastectomy and Breast Reconstruction versus Mastectomy AlonePlastic and Reconstructive Surgery, 2012
- Breast Cancer–Related Lymphedema: Comparing Direct Costs of a Prospective Surveillance Model and a Traditional Model of CarePhysical Therapy, 2012
- Voices From the ShadowsCancer Nursing, 2012
- Risk Factors for Lymphedema in a Prospective Breast Cancer Survivorship StudyArchives of Surgery, 2010
- Risk Factors for Lymphedema after Breast Cancer TreatmentCancer Epidemiology, Biomarkers & Prevention, 2010
- Lymphedema in Breast Cancer Survivors: Incidence, Degree, Time Course, Treatment, and SymptomsJournal of Clinical Oncology, 2009
- Lymphedema and Quality of Life in Breast Cancer Survivors: The Iowa Women's Health StudyJournal of Clinical Oncology, 2008
- Prevalence of Lymphedema in Women With Breast Cancer 5 Years After Sentinel Lymph Node Biopsy or Axillary Dissection: Objective MeasurementsJournal of Clinical Oncology, 2008